Central Nervous System (CNS) disorders are among the most complex and debilitating conditions, often requiring innovative approaches in both diagnosis and treatment. At mediSMART, we support the advancement of CNS drug development by delivering high-quality, patient-focused clinical research across Turkey and the MENA region.

Our experience spans phase I–IV clinical trials in a wide range of CNS indications, including:

🧠 Alzheimer's disease

🤝 Parkinson's disease

🔬 Multiple sclerosis (MS)

⚡ Epilepsy

🩺 Stroke and post-stroke recovery

🤕 Migraine

⚡ Neuropathic pain

😔 Major depressive disorder (MDD)

🧬 Schizophrenia and bipolar disorder

With access to specialized neurology and psychiatry investigators, experienced site personnel, and a growing network of CNS-focused study centers, mediSMART is equipped to meet the demands of complex protocols and long-term follow-up.

We understand the sensitivity and variability inherent in CNS studies and are committed to data quality, timely execution, and patient safety—helping sponsors bring forward the next generation of neurological and psychiatric therapies.